SB 706504

SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD)[1].


Cat. No.: EX-A14384	Purity: >98%

	Chemical structure of SB 706504

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	830	In-stock
250mg	1650	In-stock
500mg	2620	In-stock
1g	4100	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	911110-38-8
Purity	>98%
Formula	C24H19F3N8O
Mol Weight	492.4559
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Lauren M. Kent, et al. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
CoA	CoA of SB 706504

Smiles:	CC1=C(C=CC(=C1)F)C2=C3C=CC(=O)N(C3=NC(=N2)NCCN=C(N)NC#N)C4=C(C=CC=C4F)F


		Search